Diamyd Medical increases investment in Companion Medical
May 22, 2015 03:08 ET
|
Diamyd Medical AB (publ)
Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) announced today
that Diamyd Medical increases its investment in Companion Medical by USD
150,000. This is done in connection with a...
EDCR has started – first patient included in new study combining the diabetes vaccine Diamyd® with etanercept
May 20, 2015 02:30 ET
|
Diamyd Medical AB (publ)
Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) announced today
that the first patient has been included in a new study, EDCR, in which the
diabetes vaccine Diamyd® will be combined with...
EDCR har startat - första patienten inkluderad i ny studie där diabetesvaccinet Diamyd® kombineras med etanercept
May 20, 2015 02:30 ET
|
Diamyd Medical AB (publ)
Diamyd Medical (Nasdaq Stockholm First North, DMYD B) meddelar att den första
patienten nu har inkluderats i en ny studie, EDCR, där diabetesvaccinet Diamyd®
kombineras med två andra redan godkända...
Publication of change in the total number of shares and votes in Diamyd Medical AB
April 30, 2015 06:09 ET
|
Diamyd Medical AB (publ)
As of April 30, 2015, the share capital in Diamyd Medical AB (publ) is SEK
2,212,988. The total number of votes is 3,044,668 and the total number of shares
is 21,819,422, divided among 958,584 shares...
Offentliggörande av det totala antalet aktier och röster i Diamyd Medical AB
April 30, 2015 06:09 ET
|
Diamyd Medical AB (publ)
Per den 30 april 2015 uppgår aktiekapitalet i Diamyd Medical AB (publ) till
2 212 988 kronor. Det totala antalet röster uppgår till 3 044 668 och det totala
antalet aktier till 21 819 422, varav...
Diamyd Medical increases investment in stem cell activity
April 17, 2015 02:30 ET
|
Diamyd Medical AB (publ)
Diamyd Medical (Nasdaq Stockholm First North Ticker: DMYD B) announced today
that the Company invests an additional SEK 0.8 million in Cellaviva AB, Sweden's
first commercial biobank for stem...
Diamyd Medical investerar ytterligare i stamcellsverksamhet
April 17, 2015 02:30 ET
|
Diamyd Medical AB (publ)
Diamyd Medical (Nasdaq Stockholm First North, DMYD B) meddelar att Bolaget
investerar ytterligare 0,8 miljoner kronor i Cellaviva AB, Sveriges första
kommersiella biobank för stamceller.
Diamyd...
Immunological markers affected after six months in a first combination study with the diabetes vaccine Diamyd®
April 13, 2015 02:30 ET
|
Diamyd Medical AB (publ)
Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) announced today
that a first evaluation, after six months, of immunological markers in DIABGAD
has been performed. DIABGAD is one of five...
Immunologiska markörer påverkas efter sex månader i en första kombinationsstudie med diabetesvaccinet Diamyd®
April 13, 2015 02:30 ET
|
Diamyd Medical AB (publ)
Diamyd Medical (Nasdaq Stockholm First North, DMYD B) meddelar att en första
utvärdering, efter sex månader, har gjorts av immunologiska markörer i DIABGAD,
en av fem pågående kliniska studier med...
Diamyd Medical contributes to JDRF initiative to increase understanding of type 1 diabetes
April 07, 2015 02:30 ET
|
Diamyd Medical AB (publ)
Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) announced today
that the Company has joined a research initiative aimed at increasing the
understanding of the natural progression of type...